Breaking News Instant updates and real-time market news.

BAC

Bank of America

$22.94

0.39 (1.73%)

, F

Ford

$12.85

0.22 (1.74%)

08:56
01/11/17
01/11
08:56
01/11/17
08:56

Notable open interest changes for January 11th

Tuesday's total option volume of 13.8 million contracts resulted in net open interest growth of 2.22 million calls and 2.71 million puts. Bank of America (BAC), Ford (F), Intel (INTC) and Valeant (VRX) saw the greatest growth. Top five new positions opened include 31k Chesapeake (CHK) Mar-17 7 calls, 25k Intel (INTC) Feb-17 34 puts, 24k Intel (INTC) Feb-17 38 calls, 23k AK Steel (AKS) Feb-17 13 calls and 20k Southwestern Energy (SWN) Feb-17 13 calls.

BAC

Bank of America

$22.94

0.39 (1.73%)

F

Ford

$12.85

0.22 (1.74%)

INTC

Intel

$36.54

-0.07 (-0.19%)

VRX

Valeant

$16.40

1.05 (6.84%)

  • 13

    Jan

  • 16

    Feb

BAC Bank of America
$22.94

0.39 (1.73%)

01/09/17
WELS
01/09/17
NO CHANGE
WELS
Bank of America added to Priority Stock List at Wells Fargo
Wells Fargo added Bank of America to its Priority Stock List and identifies it as its top pick among large cap banks. The firm has "growing confidence" that the bank can benefit from multiple catalysts, including higher rates, prudent balance sheet growth, capital market improvement, and cost reductions.
12/21/16
ATLE
12/21/16
UPGRADE
Target $25
ATLE
Overweight
Bank of America upgraded due rising rates, lower taxes at Atlantic Equities
As previously reported, Atlantic Equities upgraded Bank of America to Overweight from Neutral with a $25 price target. Analyst Christopher Wheeler said Bank of America will be a major beneficiary of rising rates, strong capital markets, and potentially lower tax rates.
01/11/17
UBSW
01/11/17
DOWNGRADE
Target $23
UBSW
Neutral
Bank of America downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Bank of America after assuming coverage of the name. The analyst views the valuation as full following the stock's outperformance since interest rates troughed in mid- 2016. He lowered his price target for the shares to $23 from $24.
01/10/17
SBSH
01/10/17
DOWNGRADE
Target $225
SBSH
Sell
Goldman Sachs downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Goldman Sachs (GS) to Sell with a $225 price target, representing 6% downside from current levels. While higher interest rates benefit fixed income trading, the path is "relatively uncertain and the bar is relatively high" for Goldman, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally. Horowitz this morning also downgraded Comerica (CMA) to Sell while keeping Buy ratings on Wells Fargo (WFC) and Bank of America (BAC).
F Ford
$12.85

0.22 (1.74%)

12/21/16
12/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with a Buy at Seaport Global. 2. Qualcomm (QCOM) and NXP Semiconductors (NXPI) were initiated with a Neutral at Citi. 3. Mobileye (MBLY) was initiated with a Market Perform at BMO Capital and a Neutral at Susquehanna. 4. Ford (F) initiated with a Market Perform at BMO Capital. 5. Autoliv (ALV) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/28/16
PIPR
12/28/16
NO CHANGE
PIPR
Piper lays out top Auto and Truck picks into 2017
Piper Jaffray analyst Alexander Potter ranked his auto- and truck-related stocks in order of conviction heading into 2017. His top three names are General Motors (GM), Delphi (DLPH) and Mobileye (MBLY). Mobileye offers the most "compelling upside potential" at almost 70%, but also the most risk, Potter tells investors in a research note on the Autos, Trucks, and Advanced Mobility space. As such, the stock sits third behind GM and Delphi in order of preference. After a strong showing in 2016, the analyst thinks most of the truck stocks will struggle to outperform in 2017. He calls Allison Transmission (ALSN) a notable Underweight.
01/04/17
JEFF
01/04/17
NO CHANGE
Target $32
JEFF
Buy
Fox Factory price target raised to $32 from $26 at Jefferies
Jefferies analyst Trevor Young raised his price target for Fox Factory (FOXF) to $32 saying his firm's Ford (F) dealer survey bodes well for the company's power vehicle business in Q4 and FY17. The survey indicated long wait lists for the MY17 Ford F-150 Raptor and ask prices up to $20,000 above the suggested retail price for in-stock units. The analyst notes Fox Factory is the suspension supplier for the truck. Young reiterates a Buy rating on the shares.
01/03/17
LOOP
01/03/17
NO CHANGE
LOOP
Ford plant cancelation 'big hit' to Kansas City Southern auto story, says Loop
Loop Capital Markets analyst Rick Paterson said that Ford's (F) cancelled $1.6B investment in a Mexican automotive plant was "a big hit" to the Kansas City Southern (KSU) auto growth story, but noted that the remaining Mexican plant openings were from foreign companies, making them less susceptible to pressure from President-elect Trump. Paterson kept a Buy rating and $98 price target on Kansas City Southern shares.
INTC Intel
$36.54

-0.07 (-0.19%)

01/09/17
FBCO
01/09/17
NO CHANGE
FBCO
Credit Suisse sees continued Semi upside, lays out top 2017 picks
Credit Suisse analyst John Pitzer says that despite outperforming in three of the last four years, shares of Semiconductor companies have more upside. Increasing barriers to entry coupled with slowing supply growth, further industry consolidation and diversifying demand drivers should allow Semis to outgrow global nominal gross domestic product for the first time since the late 1990s, Pitzer tells investors in a research note titled "2017 Outlook: Go Secular or Go Home." He views the Semi space as the "safest/cheapest vehicle with which to exploit Data Growth." Pitzer this morning upgraded Texas Instruments (TXN) to Outperform from Neutral and Brooks Automation (BRKS) to Neutral from Underperform. He also downgraded Rudolph Technologies (RTEC) to Neural. His top picks for 2017 in order of preference are Micron (MU), Texas Instruments, Marvell (MRVL) and Intel (INTC) in Semis and Applied Materials (AMAT), KLA-Tencor (KLAC), and Lam Research (LRCX) in the Semi Equipment space.
12/13/16
LOOP
12/13/16
INITIATION
Target $40
LOOP
Buy
Intel initiated with a Buy at Loop Capital
Loop Capital analyst Betsy Van Hees initiated Intel with a Buy and a $40 price target.
12/14/16
ADAM
12/14/16
NO CHANGE
Target $13
ADAM
Buy
AMD price target raised to $13 from $8.75 at Canaccord
Canaccord analyst Matthew Ramsay raise his price target on Advanced Micro Devices (AMD) to $13 from $8.75 citing higher confidence in the company's CPU and GPU roadmaps and its gross margin expansion opportunity. Ramsay, who sees AMD re-emerging as a competitive second source to Intel (INTC) in CPU markets with its "on-track" Zen roadmap and expects a gradual unit share recovery in lower GPU market tiers, keeps a Buy rating on AMD shares.
12/20/16
12/20/16
UPGRADE
Target $13

Buy
AMD upgraded to Buy on deep learning and AI opportunity at Mizuho
As previously reported, Mizuho analyst Vijay Rakesh upgraded AMD (AMD) to Buy from Neutral, as he sees deep learning and AI as the next big computing paradigm and believes the company has an opportunity for deep learning with its new Radeon ProGFx/Ryzen products. He set a $13 price target on AMD shares. Rakesh, who said NVIDIA (NVDA) has solid traction in the initial Deep Learning space with GPUs and parallelism, raised his price target on its shares to $115 from $80, adding that while Intel (INTC) is a "late starter" and behind NVIDIA, it should also be a beneficiary of GPUs in the data center.
VRX Valeant
$16.40

1.05 (6.84%)

01/11/17
ADAM
01/11/17
NO CHANGE
Target $19
ADAM
Hold
Valeant asset sales first steps to address leverage, says Canaccord
Canaccord analyst Neil Maruoka noted Valeant's asset sales announced yesterday, calling them the company's first steps in addressing the de-leveraging of its balance sheet. He views the moves as a positive, but also said it underscores the potential challenges ahead for the company. Maruoka maintained his Hold rating and raised his price target to $19 from $17 on Valeant shares.
01/10/17
01/10/17
NO CHANGE

Wells Fargo says Valeant debt problematic, base business still weak
Wells Fargo analyst David Maris said the proceeds announced today from Valeant's sale of its Dendreon unit, CeraVe and two other products would cover some, but not all, of the approximately $3.8B in debt the company has due in 2018. Valeant has not made clear in its press releases if these deals are dilutive to EPS, noted Maris, who believes the company's debt is problematic and base business remains weak. Maris keeps an Underperform rating on Valeant shares.
01/10/17
BMOC
01/10/17
NO CHANGE
Target $21
BMOC
Market Perform
Valeant sales of Dendreon, CeraVe a 'good start,' says BMO Capital
BMO Capital analyst Gary Nachman said Valeant's (VRX) sales of Dendreon to Sanpower Group and CeraVe, AcneFree and AMBI to L'Oreal (LRLCY) for roughly $2.1B in cash have a combined average sales multiple of 4.4x, which appears to be a "solid price" and a good start for the company as it looks to sell additional assets to address its debt. Nachman also noted that Valeant announced that its second Phase 3 study for IDP-118 was successful, though he remains cautious on the drug given that most psoriasis creams are generic at this point. The analyst keeps a Market Perform rating and $21 price target on Valeant shares, which are up nearly 13% to $17.31 in pre-market trading.
01/10/17
WELS
01/10/17
NO CHANGE
WELS
Underperform
Valeant hiked prices on over 50 products last week, says Wells Fargo
Wells Fargo analyst David Maris said last night that on January 6, Valeant Pharmaceuticals implemented 95 different price increases across more than 50 products. This shows the company continues to rely on price as a means of growth and may also signal that Valeant's prescription volumes continue to remain challenged, Maris told investors in a research note. He reminds investors that Friday's price hikes "come on top of significant price increases--some of them more than 100%--taken on products in previous years and several taken in late 2016." Maris continues to believe the "new Valeant" is the "same Valeant using the same strategy and pricing levers that have been used before." The analyst keeps an Underperform rating on the shares with a $10-$13 price target range. The stock is up 12% to $17.20 in pre-market trading following the announcement of several asset sales.

TODAY'S FREE FLY STORIES

VSM

Versum Materials

$37.86

0.16 (0.42%)

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Initiation
Versum Materials initiated  »

Versum Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Syndicate
Juno Therapeutics files $225M automatic stock shelf »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

, BSTI

Best Inc.

16:16
09/20/17
09/20
16:16
09/20/17
16:16
General news
On The Fly: Top stock stories for Wednesday »

Stocks were largely on…

AAPL

Apple

$156.07

-2.66 (-1.68%)

BSTI

Best Inc.

BABA

Alibaba

$177.95

-2.12 (-1.18%)

FDX

FedEx

$220.53

4.531 (2.10%)

ADBE

Adobe

$149.96

-6.64 (-4.24%)

GIS

General Mills

$52.17

-3.215 (-5.81%)

CPRT

Copart

$33.86

1.32 (4.06%)

ALNY

Alnylam

$113.78

38.7408 (51.63%)

IONS

Ionis Pharmaceuticals

$53.88

-5.19 (-8.79%)

BBBY

Bed Bath & Beyond

$22.74

-4.29 (-15.87%)

DESP

Despegar.com

CELC

Celcuity

$14.29

14.289 (1,428,900.00%)

ZLAB

Zai Lab

KRYS

Krystal Biotech

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 22

    Oct

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

APC

Anadarko

$44.78

1.02 (2.33%)

16:15
09/20/17
09/20
16:15
09/20/17
16:15
Hot Stocks
Anadarko reaffirms production guidance »

"Separately, we want…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FCPT

Four Corners Property Trust

$25.32

0.02 (0.08%)

16:14
09/20/17
09/20
16:14
09/20/17
16:14
Hot Stocks
Four Corners Property Trust acquires 41 restaurant properties »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$44.79

1.03 (2.35%)

16:13
09/20/17
09/20
16:13
09/20/17
16:13
Hot Stocks
Anadarko targets $1B of of share repurchases prior to year-end 2017 »

Speaking about the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

, GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

16:12
09/20/17
09/20
16:12
09/20/17
16:12
Hot Stocks
GlaxoSmithKline and Innoviva report positive Phase 3 results of Treleg Ellipta »

Theravance Biopharma…

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

INVA

Innoviva

$13.59

0.08 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 24

    Oct

APC

Anadarko

$44.79

1.025 (2.34%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Anadarko announces $2.5B share repurchase program »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

QUAD

Quad/Graphics

$20.16

0.33 (1.66%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Quad/Graphics awarded $450M contract to print all Bluestem catalogs »

Quad/Graphics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MLHR

Herman Miller

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Herman Miller »

Herman Miller reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

STBZ

State Bank Financial

$27.79

0.45 (1.65%)

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
FDIC approves State Bank Financial, AloStar merger transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Hot Stocks
Herman Miller CEO says 'encouraged by the strong level of demand' »

Brian Walker, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ARCC

Ares Capital

$15.85

0.035 (0.22%)

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Initiation
Ares Capital initiated  »

Ares Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:06
09/20/17
09/20
16:06
09/20/17
16:06
Earnings
Herman Miller sees Q2 EPS 55c-61c, consensus 56c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MLHR

Herman Miller

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Earnings
Herman Miller reports Q1 adjusted EPS 57c, consensus 57c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MDXG

MiMedx

$12.34

-0.82 (-6.23%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
MiMedx responds to two "deceptive short seller articles" »

MiMedx Group responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LUNA

Luna Innovations

$1.64

0.05 (3.14%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
Luna Innovations announces stock repurchase program »

Luna Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03
Hot Stocks
Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02% »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Feb

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.